Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Zoetis Property, Plant, and Equipment 2011-2025 | ZTS

Zoetis property, plant, and equipment from 2011 to 2025. Property, plant, and equipment can be defined as the sum of all net property, plant & Equipment fields. Where companies do not report a break down of plant, property, & equipment, the value is entered in this field alone.
  • Zoetis property, plant, and equipment for the quarter ending March 31, 2025 was $3.441B, a 5.84% increase year-over-year.
  • Zoetis property, plant, and equipment for 2024 was $3.391B, a 5.84% increase from 2023.
  • Zoetis property, plant, and equipment for 2023 was $3.204B, a 16.38% increase from 2022.
  • Zoetis property, plant, and equipment for 2022 was $2.753B, a 13.67% increase from 2021.
  
Zoetis Annual Property, Plant, and Equipment
(Millions of US $)
2024 $3,391
2023 $3,204
2022 $2,753
2021 $2,422
2020 $2,202
2019 $1,940
2018 $1,658
2017 $1,435
2016 $1,381
2015 $1,307
2014 $1,318
2013 $1,295
2012 $1,241
2011 $1,243
2010 $0
Zoetis Quarterly Property, Plant, and Equipment
(Millions of US $)
2025-03-31 $3,441
2024-12-31 $3,391
2024-09-30 $3,298
2024-06-30 $3,200
2024-03-31 $3,251
2023-12-31 $3,204
2023-09-30 $3,092
2023-06-30 $3,011
2023-03-31 $2,913
2022-12-31 $2,753
2022-09-30 $2,623
2022-06-30 $2,559
2022-03-31 $2,487
2021-12-31 $2,422
2021-09-30 $2,338
2021-06-30 $2,286
2021-03-31 $2,227
2020-12-31 $2,202
2020-09-30 $2,099
2020-06-30 $2,011
2020-03-31 $1,977
2019-12-31 $1,940
2019-09-30 $1,813
2019-06-30 $1,739
2019-03-31 $1,683
2018-12-31 $1,658
2018-09-30 $1,556
2018-06-30 $1,470
2018-03-31 $1,453
2017-12-31 $1,435
2017-09-30 $1,388
2017-06-30 $1,355
2017-03-31 $1,368
2016-12-31 $1,381
2016-09-30 $1,382
2016-06-30 $1,341
2016-03-31 $1,317
2015-12-31 $1,307
2015-09-30 $1,293
2015-06-30 $1,295
2015-03-31 $1,301
2014-12-31 $1,318
2014-09-30 $1,313
2014-06-30 $1,309
2014-03-31 $1,292
2013-12-31 $1,295
2013-09-30 $1,252
2013-06-30 $1,252
2013-03-31 $1,237
2012-12-31 $1,241
2012-09-30
2012-06-30
2012-03-31
2011-12-31 $2,149
2010-12-31
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $73.286B $9.256B
Zoetis Inc. is a leader in the animal health space with a focus on both livestock and companion animals in seven major product categories: vaccines, anti-infectives, parasiticides, dermatology, other pharmaceutical products, medicated feed additives and animal health diagnostics. Zoetis has a diversified business, which caters to eight core species ' cattle, swine, poultry, fish and sheep (collectively, livestock) and dogs, cats and horses (collectively, companion animals). It directly markets its products to veterinarians and livestock producers. The outstanding growth rate in the companion animal medicines, vaccines and diagnostics sector is being driven by economic development, related increases in disposable income and a rise in pet ownership and spending on pet care.Zoetis has been working on strengthening its product portfolio through acquisitions and deals.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $88.413B 33.17
Takeda Pharmaceutical (TAK) Japan $47.888B 9.53
Daiichi Sankyo, - (DSNKY) Japan $46.809B 23.99
BeOne Medicines - (ONC) Cayman Islands $28.882B 0.00
Sandoz Group AG (SDZNY) Switzerland $23.527B 0.00
Merck (MKKGY) Germany $17.002B 12.46
Summit Therapeutics (SMMT) United States $16.012B 0.00
United Therapeutics (UTHR) United States $14.813B 13.10
Shionogi (SGIOY) Japan $14.530B 14.56
Neurocrine Biosciences (NBIX) United States $12.443B 42.62
Orion OYJ (ORINY) Finland $10.083B 27.27
IPSEN (IPSEY) France $9.974B 0.00
Corcept Therapeutics (CORT) United States $7.484B 60.84
Stevanato Group S.p.A (STVN) Italy $7.071B 43.24
Madrigal Pharmaceuticals (MDGL) United States $6.222B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.153B 0.00
Grifols, S.A (GRFS) Spain $6.071B 0.00
Ionis Pharmaceuticals (IONS) United States $5.851B 0.00
Ono Pharmaceutical (OPHLF) Japan $4.980B 15.15
Soleno Therapeutics (SLNO) United States $3.917B 0.00
Catalyst Pharmaceuticals (CPRX) United States $3.152B 11.04
Hypermarcas (HYPMY) Brazil $3.110B 20.46
Crinetics Pharmaceuticals (CRNX) United States $3.022B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.385B 12.90
BioCryst Pharmaceuticals (BCRX) United States $2.325B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $2.263B 0.00
Recursion Pharmaceuticals (RXRX) United States $2.183B 0.00
Indivior (INDV) United States $1.852B 7.85
Dyne Therapeutics (DYN) United States $1.637B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.595B 0.00
Evotec AG (EVO) Germany $1.463B 0.00
ARS Pharmaceuticals (SPRY) United States $1.427B 0.00
Ocular Therapeutix (OCUL) United States $1.418B 0.00
Guardian Pharmacy Services (GRDN) United States $1.287B 0.00
Harrow (HROW) United States $1.106B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.100B 22.00
Akebia Therapeutics (AKBA) United States $1.006B 0.00
Enliven Therapeutics (ELVN) United States $0.998B 0.00
Collegium Pharmaceutical (COLL) United States $0.978B 5.28
Avadel Pharmaceuticals (AVDL) Ireland $0.974B 0.00
Ardelyx (ARDX) United States $0.900B 0.00
Cronos Group (CRON) Canada $0.756B 0.00
KalVista Pharmaceuticals (KALV) United States $0.734B 0.00
Elite Pharmaceuticals (ELTP) United States $0.725B 0.00
Xeris Biopharma Holdings (XERS) United States $0.701B 0.00
Xencor (XNCR) United States $0.680B 0.00
Liminatus Pharma (LIMN) United States $0.676B 0.00
AleAnna (ANNA) United States $0.589B 0.00
Relay Therapeutics (RLAY) United States $0.576B 0.00
Regulus Therapeutics (RGLS) United States $0.575B 0.00
USANA Health Sciences (USNA) United States $0.555B 12.07
Bioventus (BVS) United States $0.552B 14.00
Theravance Biopharma (TBPH) United States $0.548B 0.00
Verve Therapeutics (VERV) United States $0.544B 0.00
Zevra Therapeutics (ZVRA) United States $0.503B 0.00
Tourmaline Bio (TRML) United States $0.485B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.485B 0.00
Altimmune (ALT) United States $0.483B 0.00
Oruka Therapeutics (ORKA) United States $0.470B 0.00
Organogenesis (ORGO) United States $0.436B 0.00
Siga Technologies (SIGA) United States $0.433B 9.04
Savara (SVRA) United States $0.411B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.391B 10.56
Aquestive Therapeutics (AQST) United States $0.352B 0.00
Heron Therapeutics (HRTX) United States $0.323B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.287B 0.00
ProKidney (PROK) United States $0.287B 0.00
Nature's Sunshine Products (NATR) United States $0.268B 24.73
Esperion Therapeutics (ESPR) United States $0.238B 0.00
MediWound (MDWD) Israel $0.232B 0.00
4D Molecular Therapeutics (FDMT) United States $0.222B 0.00
Nanobiotix S.A (NBTX) France $0.220B 0.00
Lyell Immunopharma (LYEL) United States $0.185B 0.00
OmniAb (OABI) United States $0.183B 0.00
Profound Medical (PROF) Canada $0.173B 0.00
Larimar Therapeutics (LRMR) United States $0.170B 0.00
Journey Medical (DERM) United States $0.167B 0.00
Avita Medical (RCEL) United States $0.162B 0.00
Aclaris Therapeutics (ACRS) United States $0.161B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.160B 0.00
Aldeyra Therapeutics (ALDX) United States $0.160B 0.00
Lexeo Therapeutics (LXEO) United States $0.145B 0.00
Inhibikase Therapeutics (IKT) United States $0.145B 0.00
Fractyl Health (GUTS) United States $0.141B 0.00
Korro Bio (KRRO) United States $0.139B 0.00
Achieve Life Sciences (ACHV) Canada $0.130B 0.00
Wellgistics Health (WGRX) United States $0.126B 0.00
Protara Therapeutics (TARA) United States $0.126B 0.00
Innate Pharma SA (IPHYF) France $0.122B 0.00
Cardiol Therapeutics (CRDL) Canada $0.119B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.113B 0.00
Nektar Therapeutics (NKTR) United States $0.109B 0.00
Unicycive Therapeutics (UNCY) United States $0.109B 0.00
Cassava Sciences (SAVA) United States $0.104B 0.00
Inotiv (NOTV) United States $0.103B 0.00
OptiNose (OPTN) United States $0.097B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.095B 0.00
Champions Oncology (CSBR) United States $0.091B 15.00
VAXART, INC (VXRT) United States $0.091B 0.00
Arch Biopartners (ACHFF) Canada $0.090B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.088B 65.44
Nutriband (NTRB) United States $0.087B 0.00
Pyxis Oncology (PYXS) United States $0.084B 0.00
Galectin Therapeutics (GALT) United States $0.084B 0.00
Dominari Holdings (DOMH) United States $0.077B 0.00
ESSA Pharma (EPIX) Canada $0.075B 0.00
Surrozen (SRZN) United States $0.075B 0.00
Vivani Medical (VANI) United States $0.068B 0.00
Prelude Therapeutics (PRLD) United States $0.067B 0.00
NRx Pharmaceuticals (NRXP) United States $0.063B 0.00
Context Therapeutics (CNTX) United States $0.063B 0.00
Assertio Holdings (ASRT) United States $0.063B 0.00
Metagenomi (MGX) United States $0.062B 0.00
Telomir Pharmaceuticals (TELO) United States $0.059B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
Gain Therapeutics (GANX) United States $0.057B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.057B 0.00
Rafael Holdings (RFL) United States $0.056B 0.00
PMV Pharmaceuticals (PMVP) United States $0.055B 0.00
Century Therapeutics (IPSC) United States $0.054B 0.00
Avalo Therapeutics (AVTX) United States $0.049B 0.00
Mural Oncology (MURA) Ireland $0.045B 0.00
ElectroCore (ECOR) United States $0.041B 0.00
Iterum Therapeutics (ITRM) Ireland $0.041B 0.00
Acrivon Therapeutics (ACRV) United States $0.040B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.039B 0.00
Karyopharm Therapeutics (KPTI) United States $0.036B 0.00
PolyPid (PYPD) Israel $0.034B 0.00
SCYNEXIS (SCYX) United States $0.034B 0.00
Tempest Therapeutics (TPST) United States $0.033B 0.00
FibroGen (FGEN) United States $0.032B 0.00
China SXT Pharmaceuticals (SXTC) China $0.031B 0.00
Jupiter Neurosciences (JUNS) United States $0.030B 0.00
Relmada Therapeutics (RLMD) United States $0.027B 0.00
Lyra Therapeutics (LYRA) United States $0.024B 0.00
CASI Pharmaceuticals (CASI) China $0.023B 0.00
Enlivex Therapeutics (ENLV) Israel $0.022B 0.00
Natural Alternatives (NAII) United States $0.021B 0.00
BioVie (BIVI) United States $0.021B 0.00
Mannatech (MTEX) United States $0.021B 0.00
BioLineRx (BLRX) Israel $0.020B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.019B 0.00
Lipocine (LPCN) United States $0.018B 0.00
DURECT (DRRX) United States $0.017B 0.00
ProPhase Labs (PRPH) United States $0.015B 0.00
VYNE Therapeutics (VYNE) United States $0.015B 0.00
TherapeuticsMD (TXMD) United States $0.014B 0.00
Scienture Holdings (SCNX) United States $0.014B 0.00
Citius Pharmaceuticals (CTXR) United States $0.014B 0.00
Cosmos Health (COSM) United States $0.014B 0.00
Phio Pharmaceuticals (PHIO) United States $0.013B 0.00
Minerva Neurosciences (NERV) United States $0.013B 2.24
Ainos (AIMD) United States $0.013B 0.00
Vivos Therapeutics (VVOS) United States $0.013B 0.00
Ernexa Therapeutics (ERNA) United States $0.012B 0.00
GlycoMimetics (GLYC) United States $0.011B 0.00
Addex Therapeutics (ADXN) Switzerland $0.011B 0.00
Mangoceuticals (MGRX) United States $0.011B 0.00
Talphera (TLPH) United States $0.011B 0.00
SHINECO (SISI) China $0.010B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.010B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.010B 0.00
Carisma Therapeutics (CARM) United States $0.009B 0.00
Traws Pharma (TRAW) United States $0.009B 0.00
Biomerica (BMRA) United States $0.009B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.007B 0.00
TransCode Therapeutics (RNAZ) United States $0.006B 0.00
Aptorum Group (APM) United Kingdom $0.006B 0.00
Plus Therapeutics (PSTV) United States $0.006B 0.00
Incannex Healthcare (IXHL) Australia $0.006B 0.00
Indaptus Therapeutics (INDP) United States $0.005B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Alaunos Therapeutics (TCRT) United States $0.005B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Redhill Biopharma (RDHL) Israel $0.005B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
PainReform (PRFX) Israel $0.004B 0.00
Jaguar Animal Health (JAGX) United States $0.004B 0.00
Heatwurx (PCSA) United States $0.004B 0.00
SciSparc (SPRC) Israel $0.004B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
Aditxt (ADTX) United States $0.003B 0.00
CERo Therapeutics Holdings (CERO) United States $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.003B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
Conduit Pharmaceuticals (CDT) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
Klotho Neurosciences (KLTO) United States $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
MEI Pharma (MEIP) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00